Stocktoria
Q/C TECHNOLOGIES, INC. QCLS
Nasdaq · stock · In Vitro & In Vivo Diagnostic Substances · website · IPO 2008-07-24
Q/C TECHNOLOGIES, INC. statistics & valuation
Market cap as of 2026-06-29. Multiples are price-derived and refreshed daily; everything else from the latest financial reports.
Profitability & efficiency
Margins and returns computed from annual filings. Falling shares outstanding = buybacks; rising = dilution. Net debt = debt − cash (negative = net cash).
Key ratios (by fiscal year)
| Ratio | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 | FY2017 | FY2016 |
|---|---|---|---|---|---|---|---|---|---|---|
| Gross margin | — | — | — | — | — | — | 30.4% | 7.6% | 24.1% | 63.4% |
| Operating margin | — | — | — | — | — | — | -220.2% | -604.0% | -168.3% | -112.4% |
| Net margin | — | — | — | — | — | — | -246.6% | -651.4% | -187.5% | -111.6% |
| FCF margin | — | — | — | — | — | — | — | -514.6% | -130.7% | -145.1% |
| Return on assets | -28.2% | -109.0% | -22.4% | -86.6% | -120.5% | -1402.1% | -35.7% | -139.0% | -78.9% | -65.0% |
| Return on equity | -53.5% | -238.6% | -32.3% | -103.4% | -126.4% | 180.5% | 166.7% | -186.0% | -97.5% | -97.5% |
| Current ratio | 3.00 | 1.40 | 1.17 | 1.95 | 12.18 | 0.06 | 6.74 | 3.38 | 4.36 | 1.88 |
Computed from company filings · US · as of 2025-12-31. Facts plus Stocktoria's own computed scores — not investment advice.